期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多西紫杉醇对非小细胞肺癌细胞株A-549放疗增敏作用及机制 被引量：2

Radiosensitization of Docetaxel on non-small cell lung cancer A-549 cell line and its mechanism
下载PDF
导出
摘要 目的:研究多西紫杉醇对体外培养非小细胞肺癌细胞的细胞周期改变和凋亡影响,及其放疗增敏的作用及机制。方法:以非小细胞肺癌细胞株A-549为实验对象,MTT法观察多西紫杉醇对A-549细胞增殖抑制;克隆形成实验分析细胞放射敏感性;流式细胞技术检测细胞周期及凋亡率。结果:多西紫杉醇对A-549细胞有生长抑制作用,且呈剂量依赖性,在较低浓度(1μg/ml)时即可降低A-549细胞的克隆形成率。各处理组细胞的细胞周期和凋亡率结果表明,多西紫杉醇+放疗组G2/M期细胞比例较其他组明显升高,差异有统计学意义(P<0.05);细胞凋亡率差异亦有统计学意义(P<0.05)。结论:多西紫杉醇在低细胞毒性浓度下对非小细胞肺癌细胞株A-549有放射增敏作用;多西紫杉醇对A-549细胞增敏其机制可能与其能改变细胞生长周期并诱导其凋亡有关。 Objective：To study the growt hinhibition and radiosensitivity effect of Docetaxel on non-small cell lung cancer A-549 cell line.Methods：MTT assay was used to test the inhibitory effect of Docetaxel on the NSCLC A-549 cell line proliferation and clonogenic assay was performed to determine the radiosensitization effect of Docetaxel on A-549 cell line.Change of cell cycle and apoptosis was detected by flowcytometry.Results：Docetaxel inhibited A-549 cell line proliferation in a dose-dependent manner.A low-cytotoxic concentration of Docetaxel at 1 μg/ml significantly reduced the cloning efficiency of A-549 cell line.Apoptosis rates and G2/M phase cell proportion in the radiation group was significantly higher in the Docetaxel ＋ radiation group compared with the other group （P0.05）.Conclusion：There was effect of radiosensitivity of A-549 cell line exposed to low-cytotoxic concentrations;the mechanism may be related with Docetaxel induced apoptosis and modified cell cycle in non-small cell lung cancer A-549 cell line.
作者 吴大鹏 李磊 程传耀
机构地区 河南大学淮河医院肿瘤科
出处 《中国当代医药》 2011年第10期18-19,共2页 China Modern Medicine
关键词 多西紫杉醇 A-549细胞株 放疗增敏 作用 Docetaxe Human lung cancer cell A-549 Radiosensitivity Effect
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1EVokes E.Trends and perspectives in muhimodality therapy of loeoregionally advanced non-small cell lung eanee[J].Lung Cancer2001,33(Suppl1):S85-S89.
  • 2Sarhan S,Kayisogullari U,Erean I,et al.Randomized phase 2 study of radiotherapy alone versus radiotherapy with paclitaxel in non-small cell lung eancer[J].J Int Med Res,2004,32(4):375.
  • 3Hwang A,Muschel RJ.Radiation and the G2 phase of the cell cycle[J].RadiatRes,1998,150(Suppl 5):852-859.
  • 4Dunne AL,MothersillC,Robson T,et al.Radiosensitization of colon cancer cell lines by docetaxe:I mechanisms of action[J].Oneol Res,2004,14(9):447-454.
  • 5Koolen SL,Beijnen JH,Sehellens JH.Intravenous-to-oral switch in anticancer chemotherapy:a focus on docetaxel and paclitaxel[J].Clin Pharmacol Ther,2010,87(1):126-129.
  • 6Kim JC,Saha D,Cao Q,et al.Enhaneement of radiation effects by combined doeetaxel and flavopiridol treatment in lung cancer cells[J].Ra diother Oneol,2004,71 (2):213-216.
  • 7Gligorov J,Lotz JP.Preclinicalpharmacology of the taxanes:implications of the differenees[J].Oncologist,2004,9(Suppl 2):3-8.
  • 8Ballestrero A,Montemurro F,Gonella R,et al.Dose-dense vinorelhine and paelitaxel with granulocytecolony-stimulating factor in metastatic breast cancer patients:anti-tumor activity and peripheral blood progenitor cell mobilization capability[J].Breast Cancer Res Treat,2003,82(3):185-190.
  • 9Tiersten AD,Nelsen C,Talbot SL,et al.A phase Ⅱ trial of doeetaxel and estramustine in patients with refractory meta-static breast carcinoma[J].Cancer,2003,97(3):537-544.
  • 10Biade S,Stobbe CC,Chapman JD.The intrinsic radiosensitivity of some human tumor cells throughout their cell cycles[J].Radiat Res,1997,147(4):416-419.

同被引文献23

  • 1李发强,李本全,冯立东,张胜.化、放疗同步治疗晚期贲门癌的疗效初探[J].现代肿瘤医学,2006,14(3):319-320. 被引量：1
  • 2McDonald JS,Smalley SR,Benedetti J,et al.Chemoradio-therapy after surgery compared with surgery alone for adenocarcinoma of the sto-mach or gastroesophageal junction[J].N Engl J Med,2001,345(10):725-730.
  • 3Sun J,Sun YH,Zeng ZC,et al.Consideration of the role of radiothera-py for abdominal lymph node metastases in patients with recurrent ga-stric cancer[J].Int.J.Radiation Oncology Biol.Phys,2010,77(2):384-391.
  • 4Jemal A,Murray T,Ward E,et al.Cancer statistics 2005[J].CA CancerJ Clin,2005,55(1):10-30.
  • 5Nagata Y,Negoro Y,Aoki T,et al.Clinical outcomes of 3D conformalhypofractionated single high-dose radiotherapy for one or two lung tu-mors using a stereotactic body frame[J].Int J Radiat Oncol BiolPhys,2002,52(4):1041-1046.
  • 6Ajani JA,Mans eld PF,Crane CH,et al.Paclitaxel-based chemoradio-therapy in localized gastric carcinoma:degree of pathologic responseand not clinical parameters dictated patient outcome[J].J Clin Oncol.2005,23(6):1237-1244.
  • 7Roth AD,Maibach B.Martinelli G,et a1.Docetaxel(Taxolere)-cispla-tin(TC):an effective drug combination in gastric carcinoma.Swiss Gro-up for Clinical Cancer Research(SAKK),and the European Institute ofOncology(EIO)[J].Ann Oncol,2000,11(3):301-306.
  • 8Dunne AL,Mothersill C,Robson T,et al.Radiosensitization of coloncancercelllinesbydocetaxel:mechanisms of action[J].Oncol Res,2004,14(9):447-454.
  • 9Gervais B,Duemlone A,Breton,et a1.Phase II randomised trial compar-ing doeetaxel given every 3 weeks with weekly schedule as second-lin-e therapy in patients with advanced non-small-cell lung cane(NSCUC)[J].Ann Oncol,2005,16(1):90-96.
  • 10Rivera F,Galán M,Tabernero J.et al.Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable,locally advanced gastric and oesophag-eal-gastric junction adenocarcinoma[J].Cancer Chemother Pharmac-ol,2011,67(1):75-82.

引证文献2

二级引证文献12

中国当代医药
2011年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部